skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: NFAT5 promotes in vivo development of murine melanoma metastasis

Journal Article · · Biochemical and Biophysical Research Communications
 [1]; ;  [1]
  1. Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South (Korea, Republic of)

Highlights: • First time to demonstrate a role of NFAT5 in the development of melanoma. • Depletion of NFAT5 suppresses cell proliferation and migration in vitro. • Depletion of NFAT5 suppresses tumor growth and metastasis in vivo. • NFAT5 as a novel therapeutic target in melanoma. Malignant melanoma is one of the most fatal and aggressive skin cancers, originating from pigment-containing melanocytes. Despite progress in clinical research, treatment options for malignant melanoma have been limited. The nuclear factor of activated T-cell 5 (NFAT5), originally identified as tonicity regulated transcription factor Ton/EBP, is now known as a carcinogenic gene in several types of cancer pathology. In this study, we knocked down NFAT5 to investigate its role in melanoma cancer. shRNA-mediated knockdown of NFAT5 led to a significant decrease in cell proliferation in vitro. Additionally, depletion of NFAT5 inhibited the cell migratory ability of B16BL6 melanoma cells and led to more accumulation at the G2/M phase of the cell cycle. Furthermore, NFAT5 was essential for the development of melanoma cancer pathophysiology in an in vivo mouse model. NFAT5 knockdown-induced tumor growth was slow and tumor volume was significantly reduced compared to mock controls. Moreover, NFAT5 knockdown was associated with a low number of metastatic nodules on the lung and liver. To our knowledge, our data demonstrate for the first time a role of NFAT5 in the development of melanoma. We provide evidence for NFAT5 as a marker of cell migration and metastasis, indicating that NFAT5 represents a novel therapeutic target in melanoma.

OSTI ID:
23107764
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 505, Issue 3; Other Information: Copyright (c) 2018 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle
Journal Article · Sat May 15 00:00:00 EDT 2021 · Experimental Cell Research · OSTI ID:23107764

Knockdown of NLE1 inhibits development of malignant melanoma in vitro and in vivo NLE1 promotes development of malignant melanoma
Journal Article · Thu Jul 15 00:00:00 EDT 2021 · Experimental Cell Research · OSTI ID:23107764

ShRNA-mediated knock-down of CXCL8 inhibits tumor growth in colorectal liver metastasis
Journal Article · Fri Jun 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23107764